Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DXK49H
|
|||
Drug Name |
CFI-402411
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1/2 | [1] | |
Company |
Treadwell Therapeutics
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | MEK kinase kinase 1 (MAP4K1) | Target Info | Inhibitor | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04521413) Safety and Efficacy Study Of CFI-402411 in Subjects With Advanced Solid Malignancies. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of Treadwell Therapeutics. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.